Meniere's disease is an idiopathic disease involving the inner ear, which is characterized by fluctuating low frequency sensorineural hearing loss, tinnitus, aural fullness, and recurrent vertigo. We could see the Meniere's disease without vestibular symptom in some cases. These cases have been reported as atypical (Cochlear) Meniere's disease. We have evaluated a patient of atypical Meniere's disease followed as sudden hearing loss with fluctuating low tone type sensorineural hearing loss without vertigo. Sudden deafness, cochlear sensorineural hearing loss, chronic progressive sensorineural hearing loss, presenile presbycusis, noise induced and autoimmune sensorineural hearing loss may be confused in diagnosis of Meniere disease.
Meniere's disease (MD) is defined by the American Academy of Otorhinolaryngology Head and Neck Surgery as an idiopathic disease involving the inner ear that is characterized by fluctuating low frequency sensorineural hearing loss (SNHL), tinnitus and aural fullness, and recurrent vertigo (1) . We could see the MD with or without vestibular symptoms. Full complement of symptoms of MD does not develop simultaneously in some cases. These cases have been reported as atypical MD (Cochlear MD). Vestibular MD is characterized by recurrent episodic vertigo but without hearing loss. In contrast, cochlear MD is defined as having fluctuating low frequency hearing loss without vertigo. Idiopathic sudden sensorineural hearing loss of low tone type with preservation of hightone hearing and without episodes of vertigo may be confused with atypical MD (2, 3) . In the present report, we have evaluated a patient of atypical MD followed as sudden hearing loss with fluctuating low tone type sensorineural hearing loss without vertigo. Figure 2 ). Idiopathic SNHL with and without endolymphatic hydrops and vestibular alterations has a high recurrence rate. The history of patient and characteristics of hearing loss are important for diagnosis. Sudden deafness, cochlear MD, cochlear SNHL, chronic progressive SNHL, presenile presbycusis, noise induced SNHL and autoimmune SNHL may be confused in diagnosis.
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Sudden SNHL is defined as an idiopathic disorder with sensorineural hearing loss of at least 30 dB over three contiguous frequencies on pure tone Discussion audiometry occurring acutely under 72 hours from initial onset (3). It has mostly involved for one ear, but sometimes bilaterally. Associated symptoms include tinnitus, vertigo, and aural fullness. The suspected etiologies for patients suffering sudden sensorineural hearing loss included idiopathic (71.0%), infectious disease (12.8%), otologic disease (4.7%), trauma (4.2%), vascular or hematologic (2.8%), neoplastic (2.3%), and other causes (2.2%) (4).
Patients should begin treatment with oral steroids within three weeks. One study found that patients with minimal hearing loss, no vestibular symptoms, and early treatment have better outcomes (4).
Autoimmune SNHL is usually bilateral. Patients present with rapidly progressive bilateral SNHL and poor speech discrimination scores, and they also may have vertigo or disequilibrium. Hearing loss progresses over three to four months, and an associated autoimmune disorder may be present. Symptoms usually improve with the administration of oral prednisone, and response to this steroid is currently the best way to make the diagnosis. Lowdose methotrexate therapy is becoming an accepted alternative to long-term prednisone therapy (5).
Meniere's disease is another cause of sensorineural hearing loss. Patients report unilateral fluctuating hearing loss with aural fullness, tinnitus, and episodic vertigo. Initially, the hearing loss is in the low frequencies, but higher frequencies are affected as the disease progresses. Treatment includes a low-salt diet, diuretics, and vestibular suppressants. Hearing aids are often ineffective because patients suffer from poor speech discrimination, as well as diminished tolerance to amplified sound. Chemical labyrinthectomy with gentamicin is now a common nonsurgical option for control of vertigo if medical management fails (6) . Full complement of symptoms of MD does not develop simultaneously in some cases. We could see the MD without vestibular symptoms. The SNHL configuration of atypical MD is not standard (7) . The audiogram and hearing fluctuation of this patient is including 500,100 and 2000 Hz low frequencies. The association of endolymphatic hydrops with fluctuating hearing loss has been shown using positive glycerol tests and histological confirmation at autopsy (2-4). Although MD has been attributed to endolymphatic hydrops, only post-mortem histopathological confirmation has been available (8) . Electrocochleography, glycerol test, or other functional testing has been utilized to estimate endolymphatic hydrops, but these do not give direct prof (1) . These limited options of clinical diagnosis and functional testing were all that were available, thus making precise diagnosis of MD difficult. A positive glycerol test suggested possible endolymphatic hydrops (Figure 2 ).
The initial diagnosis was atypical (cochlear) MD for this patient. The patient was treated with a loop diuretic and low salt diet consistent with the hydrocortisone sodium succinate (300 mg/day for 2 days, 200 mg/day for 2 days, 100 mg/day for 2 days). The patient has been treated and SNHL had got better after the medical therapy. Sudden SNHL, and autoimmune SNHL may be confused in diagnosis of the atypical MD. The history of patient and characteristics of hearing loss and differential diagnosis are important for the diagnosis of atypical MD. Right diagnosis reaches us to the right treatment options and better results as could be seen in this case.
